Bayer Considering Sale of Diabetes Device Unit -Bloomberg
November 24 2014 - 3:40PM
Dow Jones News
Bayer AG (BAYRY) is considering selling its diabetes device
business, which could fetch the Germany company up to EUR2 billion,
Bloomberg News reported Monday on its website, citing people with
knowledge of the matter.
Bayer, which has hired Credit Suisse Group AG (CS) to assist
with the process, also plans to list its plastics unit on the stock
market, Bloomberg reported.
Full story at:
www.businessweek.com/news/2014-11-24/bayer-said-to-explore-sale-of-2-dot-5-billion-diabetes-unit
Write to nymonitoring@dowjones.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
Credit Suisse (NYSE:CS)
Historical Stock Chart
From Apr 2024 to May 2024
Credit Suisse (NYSE:CS)
Historical Stock Chart
From May 2023 to May 2024